Autologous Adoptive T-cell Therapy for Recurrent or Drug-resistant Cytomegalovirus Complications in Solid Organ Transplant Recipients: A Single-arm Open-label Phase I Clinical TrialCorey Smith, Rajiv Khanna, Leone Beagley et al.|Clinical Infectious Diseases|2018Cited by 105
Incidence, Risk Factors, and Outcomes of Kidney Transplant Recipients With BK Polyomavirus-Associated NephropathyRyan Gately, Germaine Wong, Elasma Milanzi et al.|Kidney International Reports|2022Cited by 37
T cell repertoire remodeling following post-transplant T cell therapy coincides with clinical responseCorey Smith, Rajiv Khanna, Dillon Corvino et al.|Journal of Clinical Investigation|2019Cited by 24
Kidney Transplant Outcomes in elderly Recipients: An Australia and New Zealand Dialysis and Transplant (ANZDATA) Registry StudyBrian Doucet, Nicole M. Isbel, Carmel M. Hawley et al.|Transplantation Proceedings|2021Cited by 23
Prophylactic and therapeutic adenoviral vector-based multivirus-specific T-cell immunotherapy for transplant patientsVijayendra Dasari, Rajiv Khanna, Andrea Schuessler et al.|Molecular Therapy — Methods & Clinical Development|2016Cited by 18